Adherence to HU and HRQOL in Patients With Sickle Cell Disease: An Intervention Study Using HU-Go App

Clinical trial NCT04675645 · COMPLETED

Trial details

NCT number: NCT04675645
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Sickle Cell Disease Sickle B+ Thalassemia Sickle Beta Zero Thalassemia Sickle Cell Hemoglobin C

Start date: 2018-05-15
Primary completion: 2020-07-11
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.